Profile data is unavailable for this security.
About the company
Akoya Biosciences, Inc. is a life sciences technology company delivering spatial biology solutions focused on transforming discovery, clinical research, and diagnostics. It offers single-cell imaging solutions that allow researchers to phenotype cells with spatial context and visualize how they organize and interact to influence disease progression and response to therapy. It offers a full continuum of spatial phenotyping solutions to serve the diverse needs of researchers across discovery, translational and clinical research: PhenoCode Panels and PhenoCycler, PhenoImager Fusion and PhenoImager HT Instruments. Its PhenoCycler platform provides ultra-high parameter biomarker discovery, with the ability to analyze high-plex single-cell resolution across the entire tissue sample. Its PhenoImager platform enables researchers to visualize, analyze, quantify and phenotype cells in situ, in fresh frozen or formalin-fixed paraffin-embedded (FFPE) tissue sections, and tissue microarrays (TMAs).
- Revenue in USD (TTM)93.22m
- Net income in USD-60.35m
- Incorporated2015
- Employees330.00
- LocationAkoya Biosciences Inc100 Campus Drive, 6Th FloorMARLBOROUGH 01762United StatesUSA
- Phone+1 (415) 765-6980
- Websitehttps://www.akoyabio.com/
Peer analysis
- Key Information
- Stock Performance
- Per Share Data
- Efficiency
- Management Effectiveness
- Profitability
- Financial Strength
- Growth Rates
Company | Revenue (TTM) | Net income (TTM) | Market cap | Employees | Price/earnings (TTM) | Price/book value (MRQ) | Price/cash flow (TTM) | Price/sales (TTM) | EPS (excl. extraordinary items, TTM) | EPS (incl. extraordinary items, TTM) | Revenue per share (TTM) | Book value per share (MRQ) | Asset turnover (TTM) | Inventory turnover (TTM) | Receivables turnover (TTM) | Revenues per employee (TTM) | Return on avg assets (TTM) | Return on avg assets (5 yr avg) | Return on investment (TTM) | Return on investment (5 yr avg) | Gross margin (TTM) | Gross margin (5 yr avg) | Net profit margin (TTM) | Net Profit margin (5 yr avg) | Quick ratio (MRQ) | Interest coverage (TTM) | Total debt to capital (MRQ) | Payout ratio (5 yr avg) | Revenue (YOY change %) | Revenue (5 yr growth rate) | Net income (YOY change %) | Net income (5 yr growth rate) | Capital expenditure (5 yr growth rate) | Dividend (5 yr growth rate) |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Edap Tms SA (ADR) | 69.26m | -21.95m | 113.18m | 307.00 | -- | 2.13 | -- | 1.63 | -0.592 | -0.592 | 1.87 | 1.43 | 0.6992 | 2.37 | 3.42 | 225,598.80 | -22.16 | -6.62 | -31.50 | -9.22 | 40.34 | 43.23 | -31.69 | -9.59 | 1.80 | -- | 0.0599 | -- | 9.64 | 9.05 | -622.06 | -- | 32.75 | -- |
Cibus Inc | 2.96m | -291.86m | 116.51m | 183.00 | -- | 0.3403 | -- | 39.35 | -16.39 | -16.39 | 0.1545 | 11.75 | 0.0043 | -- | 3.09 | 16,180.33 | -53.70 | -86.28 | -64.26 | -96.45 | -- | -- | -12,400.74 | -792.07 | -- | -2.66 | 0.0032 | -- | 1,057.33 | 50.41 | -1,484.44 | -- | 18.53 | -- |
Myomo Inc | 21.11m | -9.45m | 117.58m | 101.00 | -- | 12.14 | -- | 5.57 | -0.2614 | -0.2614 | 0.5833 | 0.3204 | 1.43 | 3.50 | 10.13 | 209,020.40 | -64.07 | -81.78 | -101.11 | -115.27 | 67.35 | 68.50 | -44.75 | -85.76 | 1.94 | -- | 0.00 | -- | 23.70 | 51.09 | 24.00 | -- | 2.82 | -- |
Fonar Corp | 102.72m | 10.29m | 117.77m | 561.00 | 11.85 | 0.7106 | 6.24 | 1.15 | 1.48 | 1.48 | 14.72 | 24.70 | 0.5023 | 19.99 | 1.41 | 183,098.20 | 7.16 | 8.73 | 7.40 | 9.60 | 45.55 | 48.33 | 14.26 | 16.39 | 9.16 | -- | 0.0051 | -- | 1.08 | 3.89 | -24.71 | -15.05 | 8.48 | -- |
Harvard Bioscience, Inc. | 101.13m | -10.68m | 119.93m | 391.00 | -- | 1.78 | -- | 1.19 | -0.2471 | -0.2471 | 2.35 | 1.54 | 0.7441 | 1.64 | 6.88 | 258,631.70 | -7.86 | -3.29 | -9.44 | -3.89 | 58.39 | 56.67 | -10.56 | -4.57 | 0.9416 | -1.31 | 0.3467 | -- | -0.9573 | -1.45 | 64.11 | -- | 18.10 | -- |
KORU Medical Systems Inc | 30.82m | -11.76m | 123.35m | 82.00 | -- | 6.59 | -- | 4.00 | -0.2574 | -0.2574 | 0.6742 | 0.4082 | 0.9737 | 2.94 | 6.50 | 375,817.30 | -37.15 | -17.60 | -43.48 | -20.29 | 62.49 | 59.44 | -38.16 | -21.70 | 3.27 | -- | 0.0195 | -- | 2.23 | 10.44 | -58.65 | -- | 11.10 | -- |
EUDA Health Holdings Ltd | 3.71m | -8.44m | 126.46m | 106.00 | -- | -- | -- | 34.12 | -0.3685 | -0.4384 | 0.1707 | -0.3045 | 0.2752 | -- | 3.55 | 34,966.61 | -62.62 | -- | -- | -- | 22.72 | -- | -227.57 | -- | -- | -1.49 | -- | -- | -1.54 | -- | 66.17 | -- | -- | -- |
908 Devices Inc. | 52.69m | -37.99m | 127.54m | 230.00 | -- | 0.8151 | -- | 2.42 | -1.15 | -1.15 | 1.60 | 4.52 | 0.2511 | 1.54 | 4.95 | 229,069.60 | -18.11 | -14.16 | -20.12 | -15.35 | 52.32 | 53.02 | -72.10 | -64.25 | 4.23 | -- | 0.00 | -- | 7.21 | 17.89 | -8.45 | -- | 22.98 | -- |
InfuSystem Holdings Inc | 129.37m | 366.00k | 137.70m | 499.00 | 412.52 | 2.57 | 10.99 | 1.06 | 0.0157 | 0.0157 | 5.99 | 2.51 | 1.22 | 10.38 | 6.44 | 259,264.50 | 0.3465 | 4.60 | 0.401 | 5.69 | 49.68 | 56.43 | 0.2829 | 4.07 | 1.64 | 1.97 | 0.3898 | 0.00 | 14.44 | 13.38 | 4,744.44 | -- | 6.01 | -- |
Akoya Biosciences Inc | 93.22m | -60.35m | 142.56m | 330.00 | -- | 6.40 | -- | 1.53 | -1.22 | -1.22 | 1.89 | 0.4498 | 0.5605 | 1.93 | 6.34 | 282,472.70 | -36.29 | -- | -45.98 | -- | 57.57 | -- | -64.74 | -- | 1.98 | -8.00 | 0.7755 | -- | 29.09 | -- | 10.36 | -- | -- | -- |
Acme United Corp | 192.71m | 19.45m | 155.56m | 645.00 | 8.47 | 1.50 | 6.22 | 0.8072 | 4.97 | 4.97 | 48.59 | 28.13 | 1.15 | 2.07 | 4.83 | 298,770.50 | 11.60 | 7.09 | 13.79 | 8.29 | 39.40 | 35.72 | 10.09 | 5.50 | 1.77 | 6.60 | 0.2621 | 18.81 | -1.27 | 6.88 | 486.31 | 31.08 | 9.02 | 4.84 |
Semler Scientific Inc | 61.74m | 15.82m | 163.13m | 92.00 | 11.48 | 2.08 | 9.90 | 2.64 | 2.03 | 2.03 | 7.93 | 11.22 | 0.7706 | 16.26 | 9.15 | 671,097.80 | 19.74 | 38.83 | 22.00 | 44.41 | 88.67 | 90.22 | 25.62 | 32.58 | 3.66 | -- | 0.00 | -- | 20.28 | 25.98 | 43.69 | 32.64 | -0.3821 | -- |
Accuray Inc | 446.55m | -15.55m | 173.46m | 1.02k | -- | 3.81 | -- | 0.3885 | -0.1596 | -0.1596 | 4.53 | 0.4543 | 0.9423 | 2.14 | 5.36 | -- | -3.28 | -1.37 | -5.61 | -2.33 | 32.05 | 36.42 | -3.48 | -1.55 | 0.947 | 0.3757 | 0.7925 | -- | -0.2355 | 1.29 | -67.51 | -- | -- | -- |
Electromed Inc | 54.72m | 5.15m | 175.28m | 174.00 | 35.04 | 3.93 | 29.26 | 3.20 | 0.5791 | 0.5791 | 6.17 | 5.16 | 1.12 | 3.27 | 2.25 | 314,459.80 | 10.51 | 8.64 | 12.51 | 10.09 | 76.26 | 76.26 | 9.41 | 8.06 | 5.27 | -- | 0.00 | 0.00 | 13.83 | 11.82 | 62.67 | 21.06 | -22.23 | -- |
Stereotaxis Inc | 23.75m | -22.08m | 178.62m | 122.00 | -- | 15.42 | -- | 7.52 | -0.265 | -0.265 | 0.285 | 0.202 | 0.5632 | 1.14 | 5.04 | 194,639.30 | -49.21 | -25.02 | -71.93 | -34.12 | 59.28 | 67.57 | -87.38 | -41.90 | 1.53 | -- | 0.00 | -- | -4.89 | -1.82 | -12.33 | -- | 6.63 | -- |
Holder | Shares | % Held |
---|---|---|
Blue Water Life Science Advisors LPas of 30 Jun 2024 | 4.70m | 9.51% |
Polar Capital LLPas of 31 Mar 2024 | 1.58m | 3.20% |
The Vanguard Group, Inc.as of 31 Mar 2024 | 1.41m | 2.86% |
BlackRock Fund Advisorsas of 31 Mar 2024 | 1.20m | 2.44% |
Parkman Healthcare Partners LLCas of 31 Mar 2024 | 917.44k | 1.86% |
Uniplan Investment Counsel, Inc.as of 31 Mar 2024 | 699.84k | 1.42% |
Silvercrest Asset Management Group LLCas of 31 Mar 2024 | 580.83k | 1.18% |
Geode Capital Management LLCas of 30 Jun 2024 | 562.12k | 1.14% |
SVB Wealth LLCas of 30 Jun 2024 | 515.32k | 1.04% |
SSgA Funds Management, Inc.as of 31 Mar 2024 | 428.33k | 0.87% |